Before considering AI or advanced analytics, emerging biopharmas must first establish a solid data foundation. Without well-structured, high-quality data, even the best AI tools will fail to deliver reliable insights. In Pharmeceutical Executive, Todd Foster and Yair Markovits share guidance that emerging biopharmas can use to navigate early commercial data and analytics decisions for launch and to future-proof their data management.